Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutationJunko Tanizaki, Eri Banno, Yosuke Togashi, et al.
Oncotarget|May 17, 2018
Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of <i>EGFR</i> or <i>HER2</i>Masayuki Takeda, Kazuko Sakai, Hidetoshi Hayashi, et al.
Cancer Diagnosis & Prognosis|March 4, 2026
Development of Second Primary Malignancies in Long-term Survivors of Unresectable Esophageal CancerRyotaro Watanabe, Seiichiro Mitani, Masaki Okura, et al.
JTO Clinical and Research Reports|October 3, 2025
What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?Sun Min Lim, Joo Sung Gabriel Shim, Hyo Sup Shim, et al.
Molecular Cancer Therapeutics|August 26, 2017
T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non-Small Cell Lung CancerSatomi Watanabe, Takeshi Yoshida, Hisato Kawakami, et al.
Cancer Medicine|February 1, 2019
Targeting of the HER2/HER3 signaling axis overcomes ligand-mediated resistance to trastuzumab in HER2-positive breast cancerSatomi Watanabe, Kimio Yonesaka, Junko Tanizaki, et al.
Gynecologic Oncology Reports|October 5, 2020
A case of sarcomatoid malignant peritoneal mesothelioma diagnosed by laparoscopyMariya Kobayashi, Kumi Masuda, Yuri Noda, et al.
Pageof 7